- Home
- VIR vs ARR Comparison
VIR vs ARR Comparison
Compare VIR & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- ARR
- Stock Information
- Founded
- VIR 2016
- ARR 2008
- Country
- VIR United States
- ARR United States
- Employees
- VIR N/A
- ARR N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- ARR Real Estate Investment Trusts
- Sector
- VIR Health Care
- ARR Real Estate
- Exchange
- VIR Nasdaq
- ARR Nasdaq
- Market Cap
- VIR 706.4M
- ARR 1.3B
- IPO Year
- VIR 2019
- ARR N/A
- Fundamental
- Price
- VIR $5.65
- ARR $16.85
- Analyst Decision
- VIR Strong Buy
- ARR Hold
- Analyst Count
- VIR 8
- ARR 6
- Target Price
- VIR $30.25
- ARR $18.50
- AVG Volume (30 Days)
- VIR 1.2M
- ARR 2.7M
- Earning Date
- VIR 07-31-2025
- ARR 07-23-2025
- Dividend Yield
- VIR N/A
- ARR 17.09%
- EPS Growth
- VIR N/A
- ARR N/A
- EPS
- VIR N/A
- ARR N/A
- Revenue
- VIR $20,861,000.00
- ARR $44,778,000.00
- Revenue This Year
- VIR N/A
- ARR $532.77
- Revenue Next Year
- VIR $0.62
- ARR $15.62
- P/E Ratio
- VIR N/A
- ARR N/A
- Revenue Growth
- VIR N/A
- ARR 41.14
- 52 Week Low
- VIR $4.32
- ARR $13.18
- 52 Week High
- VIR $14.45
- ARR $21.93
- Technical
- Relative Strength Index (RSI)
- VIR 57.21
- ARR 56.36
- Support Level
- VIR $5.20
- ARR $16.62
- Resistance Level
- VIR $6.23
- ARR $16.98
- Average True Range (ATR)
- VIR 0.30
- ARR 0.22
- MACD
- VIR 0.07
- ARR 0.02
- Stochastic Oscillator
- VIR 56.06
- ARR 85.71
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.